Adma Biologics ADMA
NASDAQ ADMA
$12.79 +0.06 (+0.47%)
At close: Nov 9, 2026 · 4:00 PM EST

Adma Biologics (ADMA) Cost of Revenue (2011 - 2026)

Updated

Adma Biologics (ADMA) posted Cost of Revenue of $41.19 million for Q3 2026, down 29.7% from $58.6 million a year earlier but up 8.0% from the prior quarter.

Analysis

Adma Biologics (ADMA) Cost of Revenue (2011 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Cost of Revenue at Adma Biologics was $163.39 million, down 26.2% year-over-year; for FY2025, it came in at $217.41 million, up 5.1% from FY2024.

  • Annual Cost of Revenue has increased for six consecutive years, with a five-year compound annual growth rate of 28.8% (FY2020 to FY2025).
  • In prior years, Adma Biologics' Cost of Revenue was $206.9 million in FY2024 (+22.2%), $169.27 million in FY2023 (+42.5%), $118.82 million in FY2022 (+48.9%) and $79.77 million in FY2021 (+30.1%).
  • Quarterly Cost of Revenue has run from a low of $22.87 million in Q4 2021 to a high of $60.18 million in Q3 2024 over five years.
  • On a year-over-year basis, Cost of Revenue has declined in each of the last five quarters, with an average decline of 5.6% over the last eight quarters.
  • The strongest year-over-year quarter for Cost of Revenue in the past five years was Q2 2023, with growth of 66.2%; the weakest was Q1 2026, with a decline of 37.2%.
  • According to Business Quant data, Cost of Revenue for the three prior quarters was $38.12 million (Q2 2026), $33.74 million (Q1 2026) and $50.35 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 8.10 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 4.29 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 1.57 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 4.03 Bn
10 Adma Biologics 2.87 Bn 2.39 Bn 99.92 Mn 41.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 41.19 Mn
Jun 30, 2026 38.12 Mn
Mar 31, 2026 33.74 Mn
Dec 31, 2025 50.35 Mn
Sep 30, 2025 58.60 Mn
Jun 30, 2025 54.76 Mn
Mar 31, 2025 53.71 Mn
Dec 31, 2024 54.22 Mn
Sep 30, 2024 60.18 Mn
Jun 30, 2024 49.74 Mn
Mar 31, 2024 42.77 Mn
Dec 31, 2023 42.82 Mn
Sep 30, 2023 42.62 Mn
Jun 30, 2023 43.43 Mn
Mar 31, 2023 40.40 Mn
Dec 31, 2022 35.80 Mn
Sep 30, 2022 31.43 Mn
Jun 30, 2022 26.14 Mn
Mar 31, 2022 25.44 Mn
Dec 31, 2021 22.87 Mn
API Access

Adma Biologics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ADMA&period=max&api_key=YOUR_API_KEY